Multiple Myeloma Clinical Trials

A listing of Multiple Myeloma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 210 clinical trials
Study of AO-176 as Monotherapy and in Combination With Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma

and bortezomib in adults with relapsed/refractory multiple myeloma (MM).

refractory multiple myeloma
bortezomib
measurable disease
dexamethasone
cancer
  • 0 views
  • 03 May, 2022
  • 6 locations
A Study of JNJ-68284528 Out-of-Specification (OOS) for Commercial Release in Participants With Multiple Myeloma

The purpose of this study is to evaluate the efficacy and safety of cilta-cel out-of-specification (OOS).

human chorionic gonadotropin
fludarabine
chemotherapy regimen
  • 0 views
  • 09 May, 2022
  • 1 location
A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma (CAMMA 1)

dexamethasone (Pd) or cevostamab plus daratumumab and dexamethasone (Dd) which will be administered to participants with relapsed or refractory multiple myeloma (R/R MM) via intravenous (IV) infusion.

refractory multiple myeloma
bone marrow procedure
measurable disease
dexamethasone
cancer
  • 0 views
  • 11 May, 2022
  • 5 locations
Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)

A phase 1b/2, open label, multi-center, Clinical Study of Chimeric Antigen Receptor T Cells targeting BCMA in patients with relapsed and or refractory multiple myeloma.

refractory multiple myeloma
bcma
daratumumab
proteasome inhibitor
immunomodulatory imide drug
  • 55 views
  • 16 May, 2022
  • 11 locations
Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma

This phase II trial studies the effect of immunomodulatory drug(s) in combination with a corticosteroid drug in treating patients with multiple myeloma or smoldering multiple myeloma

anemia
neutrophil count
hypercalcemia
refractory multiple myeloma
bone marrow procedure
  • 0 views
  • 14 Apr, 2022
  • 1 location
Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma

/Refractory (r/r) Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM) administered according to different dosing schedules as a single agent and in combination with dexamethasone.

multiple myeloma
bone marrow procedure
lymphoma
antibody therapy
tyrosine
  • 0 views
  • 01 May, 2022
  • 11 locations
Daratumumab for First Line Treatment of Transplant-ineligible Myeloma Patients Followed by Daratumumab Re-treatment at First Relapse (GMMG-DADA)

Daratumumab for first line treatment of transplant-ineligible myeloma patients followed by daratumumab re-treatment at first relapse (GMMG-DADA)

bortezomib
lenalidomide
dexamethasone
  • 0 views
  • 23 Apr, 2022
  • 1 location
To Evaluate the Safety and Efficacy of Human Derived Anti-BCMA CAR-T Injection for Subjects With R/R MM

, and to preliminarily observe the efficacy of the trial drug in patients with relapsed/refractory multiple myeloma.

refractory multiple myeloma
  • 0 views
  • 18 Apr, 2022
  • 1 location
A Study to Evaluate the Safety and Pharmacokinetics of XMAB24306 in Combination With Daratumumab in Participants With Relapsed/Refractory Multiple Myeloma

This study will evaluate the safety, tolerability, pharmacokinetics, and activity of XmAb24306 in combination with a multiple myeloma (MM)-targeting monoclonal antibody capable of inducing

refractory multiple myeloma
measurable disease
  • 0 views
  • 14 May, 2022
  • 1 location
ATG-010(Selinexor) in Combination With Chemotherapy in RRMM

This is a single-arm that includes two experimental arms,Selinexor(ATG-010) in Combination with Chemotherapy to Treat Relapsed/Refractory Multiple Myeloma Patients.To evaluate efficacy and

refractory multiple myeloma
dexamethasone
chemotherapy regimen
doxorubicin
  • 0 views
  • 15 May, 2022
  • 1 location